Tower View Wealth Management’s Alpha Tau Medical DRTS Stock Holding History

Tower View Wealth Management’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70K	Hold	5,566	–	–	0.03%	95
2026 Q1	$39.4K	Hold	5,566	–	–	0.02%	102
2025 Q4	$27.6K	Hold	5,566	–	–	0.01%	102
2025 Q3	$25.1K	Hold	5,566	–	–	0.01%	103
2025 Q2	$17.4K	Hold	5,566	–	–	0.01%	123
2025 Q1	$14K	Hold	5,566	–	–	0.01%	120
2024 Q4	$17.3K	Hold	5,566	–	–	0.01%	109
2024 Q3	$13.2K	Hold	5,566	–	–	0.01%	124
2024 Q2	$14.1K	Hold	5,566	–	–	0.01%	118
2024 Q1	$16.4K	Hold	5,566	–	–	0.01%	118
2023 Q4	$17K	Hold	5,566	–	–	0.01%	112
2023 Q3	$21K	Hold	5,566	–	–	0.01%	98
2023 Q2	$24K	Hold	5,566	–	–	0.02%	95
2023 Q1	$16K	Hold	5,566	–	–	0.01%	103
2022 Q4	$18K	Hold	5,566	–	–	0.01%	102
2022 Q3	$33K	Buy	+5,566	New	+$49.1K	0.03%	89

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Tower View Wealth Management's DRTS Position: Q2 2026 in Review

Tower View Wealth Management held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 5,566 shares worth $70K. The position accounts for 0.03% of the portfolio, ranked #95.

Tower View Wealth Management first reported a position in DRTS in Q3 2022 and has held it in 16 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Tower View Wealth Management held 5,566 shares of Alpha Tau Medical worth $70K as of Q2 2026.
Tower View Wealth Management left its Alpha Tau Medical share count unchanged in Q2 2026.
Alpha Tau Medical made up 0.03% of Tower View Wealth Management's portfolio in Q2 2026, its #95 holding.
Tower View Wealth Management first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 16 quarters since.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.